Govt Approved ₹480 Crore To Develop Talent Pool For Medical Devices Sector

NEW DELHI : The government has approved a rs 480 crore scheme to develop a talent pool that will drive the medical devices industry.

The three-year scheme will provide financial assistance to government institutions for running multiple courses on medical devices, upgrading such institutions to global standards.

The move follows the recent announcement of the National Medical Device Policy, 2023, that will help the medical devices sector grow from the present $11 billion to $50 billion by 2030.

“There is a need to have a steady supply of skilled workforce across the medical device sector. For skilling, reskilling and upskilling of professionals in the medical sector, the department may leverage the available resources in ministry of skill development and entrepreneurship,” said an official from the department of pharmaceuticals.

Beside this, the new scheme will support dedicated multidisciplinary courses for medical devices in existing institutions to ensure availability of skilled manpower for futuristic medical technologies, high-end manufacturing and research.

These in turn will produce future-ready medtech human resources and meet the evolving needs of the sector.

“The plan is also to leverage partnerships with foreign academia or industry organizations to develop medical technologies so that India can compete with the world market,” said the official.

India is 80% dependent on imported medical devices.

Industry experts say that the covid-19 pandemic brought the government focus on medical devices when international supply chains became disrupted.

This prompted India to take urgent steps to manufacture masks, PPE kits, gloves, sanitizers, thermometers, oximeters and oxygen therapy equipment like invasive and non-invasive ventilators, which were imported.

“India is 75-80% import dependent with last two years imports being over ₹60,000 crore and this year the government announced the Medical Devices Policy in which a key strategy indicator was Human Resources Development. We are glad that the policy is being backed by financial outlay to enable government institutions to make tailor-made courses to develop expertise in diverse technologies deployed in medical devices–electronics, metallurgy, electrical, polymer, rubber, chemical and biomedical engineering along with nanotechnology with regulatory and quality management systems,” said Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AIMED).

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines